SC586903 · Active · incorporated 8 years, 9 months ago · Edinburgh
Biotech Biotech & Life Sciences Drug Discovery Medical Devices Series B+
Invizius is a clinical-stage biotech company developing second-generation complement therapies, including its H-Guard® technology for dialysis.
Invizius Limited is a private limited company registered at Companies House under number SC586903, incorporated on 26 January 2018, with a registered office in Edinburgh. Its current status on the register is active. Its filed nature of business covers manufacture of pharmaceutical preparations (SIC 21200) and manufacture of medical and dental instruments and supplies (SIC 32500). Sonde has indexed 92 filings for this company, including 6 funding rounds. Its most recent round closed in July 2025, raising £1.1m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Jul 2025 | £1.1m | £12.00 |
| Round 5 | Jul 2024 | £958k | £12.00 |
| Round 4 | Dec 2022 | £3.4m | £12.00 |
| Round 3 | Jun 2021 | £5.5m | £10.51 |
| Round 2 | Sep 2019 | £2.8m | £8.99 |
| Round 1 | Apr 2018 | £500k | £7.41 |
Showing the 10 most recent of 92 filings.
See the complete cap table with every shareholder, founder tags, dilution across 25 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.